The Development of Carbohydrate-Based Influenza Virus Sialidase Inhibitors
摘要：
This chapter presents a review of the development of influenza virus sialidase inhibitors based on a carbohydrate scaffold, predominantly that of the natural 'ligand' of the enzyme, N- acetylneuraminic acid (Neu5Ac). These inhibitors include hydrolytically stable substrate-like compounds, product mimics, and transition-state-like compounds. The major focus of the chapter, reflecting the most intensively researched area of inhibitor development, is on the use of the dihydropyran scaffold of the 2,3-unsaturated-Neu5Ac derivative, Neu5Ac2en, a putative transition state mimic. Structure-based drug design targeting conserved residues of the sialidase active site using this template leading to the development of the potent and selective inhibitor, and anti-influenza drug, zanamivir (Relenza), as well as subsequent developments towards next generation inhibitors, are discussed.These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
展开
DOI：
10.1007/978-3-7643-8927-7_5
年份：
2012
相似文献
参考文献
引证文献
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
